Mario Naranjo-Tovar, MD, MHS, Assistant Professor of Clinical Thoracic Medicine and Surgery at the Lewis Katz School of Medicine at Temple University, was interviewed by Healio regarding a recent study published in BMC Pulmonary Medicine. The research focused on a risk assessment tool that uses five factors to determine whether patients with chronic lung disease and pulmonary hypertension are at high, intermediate, or low risk for 1-year mortality.
Dr. Naranjo-Tovar discussed the findings and implications of this tool for patient care. The interview aimed to highlight how such tools can help clinicians better assess risks and guide treatment decisions for individuals facing these conditions.
No additional information was provided about Jeanes Hospital’s involvement in the study or its application of the risk assessment tool.
